Pharmaceutical Microbiology East Coast Conference

Discussing best practices and techniques to tackle microbial control challenges

Boston, MA, United States

The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation.

Benefits of Attending

Developing on the success of our Pharmaceutical Microbiology portfolio, our East Coast event will bring together leaders in the field to discuss the latest developments within pharmaceutical microbiology. Discover how you can keep up with regulatory changes; and maintain the utmost efficiency during production and testing.

At the 2nd Annual Pharmaceutical Microbiology East Coast Conference, you will gain insight into:

  • Design, validation and implementation of a documented and approved disinfectant programme
  • Effective use of environmental monitoring data trending
  • Rapid microbial methods
  • Challenges with endotoxin control
  • Advances in sterility assurance technology
  • Current regulations, challenges and trends in mycoplasma safety testing
  • A "deep dive" case study of atypical, low-level mold contamination

Plus Two Interactive Half-Day Post-Conference Workshops | Friday 12th April 2019

Workshop A: Mold Contamination Challenges
Workshop Leader: Ziva Abraham, CEO, Microrite, Inc
8.30 - 12.30

Workshop B: Microbiological control of GMP using Vapour Phase Hydrogen Peroxide bio-decontamination
Workshop Leader: James Drinkwater, Chairman, PHSS, Head of Aseptic Processing Technologies & GMP Compliance, Franz Ziel GmbH
13.30 - 17.30


  • Andrew Bartko, Research Leader, Battelle Memorial Institute
  • Austin Kuo, Principal Research Scientist, Sterility Assurance, Eli Lilly And Company
  • Cheryl Essex, Head of Biologics Microbiological Control, Sanofi
  • Clyde Schultz, Global Director, Celgene
  • David Hussong, Former Associate Director for New Drug Microbiology, FDA
  • Frederic Ayers, Consultant Scientist, Eli Lilly And Company
  • Hilary Chan, Principal QC Scientist, Takeda (Shire)
  • James Drinkwater, Chairman, Pharmaceutical and Healthcare Sciences Society
  • Jarrod Murphy, Supervisor, Genentech
  • Jim Polarine, Senior Technical Service Manager, STERIS Corporation
  • Leslie Falco, Microbial Control Strategist , Pfizer Inc
  • Matts Ramstorp, Professor in Cleanroom Technology, BioTekPro AB
  • Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
  • Rosemary Versteegen, CEO, International Serum Industry Association
  • Shahram Lavasani, CEO, ImmuneBiotech AB
  • Steven A. Wieczorek, Associate Director, Quality Control Microbiology, Sanofi
  • Sunhee Hong, Senior. Staff Scientist, Charles River
  • Tony Cundell, Principal Consultant, Microbiological Consulting, LLC
  • Veronika Wills, Associate Manager of Technical Services, Associates of Cape Cod
  • Ziva Abraham, CEO, Microrite, Inc.


Battery Wharf Hotel
3 Battery Wharf
Boston, MA, USA